Key facts for J1568
- Billing unit
- 500 MG
- Octagam injection
- ASP payment limit
- $47.133
- October 2026; +0.2% vs July 2026
- Practitioner MUE
- 300
- MAI 3
- NCCI exposure
- no PTP pairs
- Coverage articles
- 8
- 29 states
TL;DR
HCPCS J1568 is the Level II code for Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg, billed per 500 MG. The Medicare Part B ASP payment limit for October 2026 is $47.133 per billing unit, up 0.2% from July 2026. The practitioner MUE allows up to 300 units per date of service (MAI 3), so a full 300-unit day is $14,139.90 at the current limit. Under OPPS it carries status indicator K in APC 0943. J1568 is billed in units of 500 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names immune globulin: J1569 (Gammagard Liquid from Takeda Pharmaceuticals America, Inc); J1566 (Gammagard S/D from Takeda Pharmaceuticals America, Inc.; lyophilized, powder); J1561 (Gamunex-C/Gammaked); J1576 (Panzyga); J1557 (Gammaplex from Bio Products Laboratory); J1556 (Bivigam from ADMA Biologics, Inc). The ASP crosswalk maps 18 NDCs to it, sold as Octagam by Pfizer Inc, Octapharma USA Inc. 8 Medicare coverage articles list the code across 26 states plus DC and 2 territories, including A56718.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for J1568 at $47.133 per 500 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $47.056 in July 2026. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $47.133 | 500 MG | 20% |
| July 2026 | $47.056 | 500 MG | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 18 NDCs from 2 labelers to J1568. Report the NDC in the claim's drug segment and bill the number of J1568 units that equals the quantity administered divided by 500 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 00069-6002-02 | Octagam | Pfizer Inc | 20 × 1 | 4 |
| 00069-6111-02 | Octagam | Pfizer Inc | 100 × 1 | 20 |
| 00069-6237-02 | Octagam | Pfizer Inc | 200 × 1 | 40 |
| 00069-6339-02 | Octagam | Pfizer Inc | 300 × 1 | 60 |
| 00069-6550-02 | Octagam | Pfizer Inc | 50 × 1 | 10 |
| 00069-8400-02 | Octagam | Pfizer Inc | 20 × 1 | 2 |
| 00069-8425-02 | Octagam | Pfizer Inc | 50 × 1 | 5 |
| 00069-8451-02 | Octagam | Pfizer Inc | 100 × 1 | 10 |
| 00069-8476-02 | Octagam | Pfizer Inc | 200 × 1 | 20 |
| 68982-0840-01 | Octagam | Octapharma USA Inc. | 20 × 1 | 2 |
| 68982-0840-02 | Octagam | Octapharma USA Inc. | 50 × 1 | 5 |
| 68982-0840-03 | Octagam | Octapharma USA Inc. | 100 × 1 | 10 |
| 68982-0840-04 | Octagam | Octapharma USA Inc. | 200 × 1 | 20 |
| 68982-0850-01 | Octagam | Octapharma USA Inc. | 20 × 1 | 4 |
| 68982-0850-02 | Octagam | Octapharma USA Inc. | 50 × 1 | 10 |
| 68982-0850-03 | Octagam | Octapharma USA Inc. | 100 × 1 | 20 |
| 68982-0850-04 | Octagam | Octapharma USA Inc. | 200 × 1 | 40 |
| 68982-0850-05 | Octagam | Octapharma USA Inc. | 300 × 1 | 60 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for J1568. For practitioners the limit is 300 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 300 | 3 Date of Service Edit: Clinical | Clinical: Data |
| Facility outpatient hospital | 300 | 3 Date of Service Edit: Clinical | Clinical: Data |
| DME supplier | 300 | 3 Date of Service Edit: Clinical | Clinical: Data |
MUE for J1568 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists J1568 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check J1568 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
J1568 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
8 current Medicare Administrative Contractor articles list J1568 in their HCPCS tables, covering 29 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.
| Article | Title | Contractor(s) | States | Related LCD |
|---|---|---|---|---|
| A56718 | Billing and Coding: Intravenous Immunoglobulin (IVIG) | Palmetto GBA | NC SC VA WV | L34580 |
| A56779 | Billing and Coding: Intravenous Immune Globulin | CGS Administrators, LLC | KY OH | L35891 |
| A56786 | Billing and Coding: Immune Globulin | Novitas Solutions, Inc. | DC DE MD NJ PA | L35093 |
| A57160 | Billing and Coding: Immune Thrombocytopenia (ITP) Therapy | CGS Administrators, LLC | KY OH | L38268 |
| A57187 | Billing and Coding: Immune Globulin Intravenous (IVIg) | Noridian Healthcare Solutions, LLC | AZ MT ND SD UT WY | L34314 |
| A57554 | Billing and Coding: Immune Globulins | Wisconsin Physicians Service Insurance Corporation | IA KS MO NE | L34771 |
| A57778 | Billing and Coding: Immune Globulin | First Coast Service Options, Inc. | FL PR VI | L34007 |
| A59105 | Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG) | Wellpoint Federal | CT IL MN NY WI | L39314 |
Diagnoses Medicare contractors cover for J1568
8 billing and coding articles attach a covered diagnosis list to J1568: 453 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).
| ICD-10-CM | Description (FY2027) | Articles covering |
|---|---|---|
| D69.3 | Immune thrombocytopenic purpura | 8 of 8 |
| C90.00 | Multiple myeloma not having achieved remission | 7 of 8 |
| C91.10 | Chronic lymphocytic leukemia of B-cell type not having achieved remission | 7 of 8 |
| C91.12 | Chronic lymphocytic leukemia of B-cell type in relapse | 7 of 8 |
| D59.0 | Drug-induced autoimmune hemolytic anemia | 7 of 8 |
| D59.11 | Warm autoimmune hemolytic anemia | 7 of 8 |
| D59.12 | Cold autoimmune hemolytic anemia | 7 of 8 |
| D59.13 | Mixed type autoimmune hemolytic anemia | 7 of 8 |
| D80.0 | Hereditary hypogammaglobulinemia | 7 of 8 |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] | 7 of 8 |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses | 7 of 8 |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] | 7 of 8 |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] | 7 of 8 |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia | 7 of 8 |
| D80.7 | Transient hypogammaglobulinemia of infancy | 7 of 8 |
Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J1568 are counted here: a group whose instructions name J1568, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.
| Article | Contractor | Groups that apply | Covered codes for J1568 | Full list |
|---|---|---|---|---|
| A56718 | Palmetto GBA | one list for every code in the article | 212 | On LCD L34580 |
| A56779 | CGS Administrators, LLC | one list for every code in the article | 104 | On LCD L35891 |
| A56786 | Novitas Solutions, Inc. | group 1 applies to J1568 | 108 | On LCD L35093 |
| A57160 | CGS Administrators, LLC | one list for every code in the article | 1 | On LCD L38268 |
| A57187 | Noridian Healthcare Solutions, LLC | one list for every code in the article | 103 | On LCD L34314 |
| A57554 | Wisconsin Physicians Service Insurance Corporation | group 13 applies to J1568 | 183 | On LCD L34771 |
| A57778 | First Coast Service Options, Inc. | group 1 applies to J1568 | 108 | On LCD L34007 |
| A59105 | Wellpoint Federal | one list for every code in the article | 307 | On LCD L39314 |
Local coverage policies that list J1568
9 active Local Coverage Determinations list J1568 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- LCD L33610: Intravenous Immune Globulin · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
- Immune Globulin Intravenous (IVIg), LCD L34314 · Noridian Healthcare Solutions, LLC
- Intravenous Immunoglobulin (IVIG) (L34580) · Palmetto GBA
- LCD L34771: Immune Globulins · Wisconsin Physicians Service Insurance Corporation
- Immune Globulin, LCD L35093 · Novitas Solutions, Inc.
- Immune Thrombocytopenia (ITP) Therapy (L38268) · CGS Administrators, LLC
- LCD L39314: Off-Label Use of Intravenous Immune Globulin (IVIG) · Wellpoint Federal
- L34007 Immune Globulin · First Coast Service Options, Inc.
- L35891 Intravenous Immune Globulin · CGS Administrators, LLC
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, J1568 carries status indicator K and is assigned to APC 0943, with a published national unadjusted payment of $47.133. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), J1568 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $47.13 per 500 MG, paid only when the drug is furnished integral to a covered surgical procedure.
Common denials for J1568 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for J1568
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS J1568
What does HCPCS code J1568 describe?
J1568 is defined by CMS as "Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg". Each billing unit represents 500 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is J1568 a CPT code?
No. J1568 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as immune globulin (Octagam); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1568 reports the drug itself in 500 mg units, and the administration is billed on its own line.
What is the Medicare reimbursement for J1568 in October 2026?
The ASP-based payment limit is $47.133 per 500 MG, with 20% beneficiary coinsurance. The July 2026 limit was $47.056. Commercial payers use their own fee schedules.
How many units of J1568 can be billed per day?
The practitioner Medically Unlikely Edit is 300 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.
Which NDCs map to J1568?
The October 2026 ASP crosswalk lists 18 NDCs from 2 labelers: Octagam (Pfizer Inc); Octagam (Octapharma USA Inc.). For example NDC 00069-6002-02 (package size 20) equals 4 billing units of J1568.
Does J1568 have NCCI bundling edits?
No active practitioner PTP pairs list J1568 as a column-1 or column-2 code in the v323r0 release.
J1568 vs J1569: what is the difference?
Both are HCPCS Level II codes whose descriptor names immune globulin. What sets J1569 apart: Gammagard Liquid from Takeda Pharmaceuticals America, Inc. J1568 is billed per 500 mg, limit $47.133, MUE 300; J1569 is billed per 500 mg, limit $49.495, MUE 400. Report the code whose descriptor matches the product and setting in the record.
J1568 vs J1566: what is the difference?
Both are HCPCS Level II codes whose descriptor names immune globulin. What sets J1566 apart: Gammagard S/D from Takeda Pharmaceuticals America, Inc.; lyophilized, powder. J1568 is billed per 500 mg, limit $47.133, MUE 300; J1566 is billed per 500 mg, limit $82.756, MUE 300. Report the code whose descriptor matches the product and setting in the record.
Which Medicare coverage articles mention J1568?
8 current Billing and Coding Articles in the Medicare Coverage Database list J1568, covering 26 states plus DC and 2 territories: A56718 (Billing and Coding: Intravenous Immunoglobulin (IVIG)); A56779 (Billing and Coding: Intravenous Immune Globulin); A56786 (Billing and Coding: Immune Globulin).
What diagnosis codes support J1568?
8 Medicare billing and coding articles list 453 covered ICD-10-CM codes for J1568 between them, for example D69.3 (Immune thrombocytopenic purpura); C90.00 (Multiple myeloma not having achieved remission); C91.10 (Chronic lymphocytic leukemia of B-cell type not having achieved remission); C91.12 (Chronic lymphocytic leukemia of B-cell type in relapse); D59.0 (Drug-induced autoimmune hemolytic anemia). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.
CMS guidance
The Medicare Learning Network publication that CMS issues on this topic, cited by ICN and publication date:
- Intravenous Immune Globulin Items & Services(MLN3191598, )Home IVIG: the Q2052 service code and the immune globulin drug codes it is paired with.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- ICD-10-CM FY2027 code descriptionsVersion FY2027 · effective 2026-10-01 · file icd10cm_codes_2027.txtSHA-256 3c0583a38ee0e848…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.